Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract Health Condition 2: N858- Other specified noninflammatory disorders of uterus Health Condition 3: O- Medical and Surgical
Conditions
Interventions
Intervention1: Dexmedetomidine: Dose:50 mcg (0.5 ml of dexmedetomidine of concentration 100 mcg per ml)added to 10 ml of 2% lignocaine making a total volume of 10.5 ml given as paracervical block at
Sponsors
Aysha Rinsha T P
Eligibility
Inclusion criteria
Inclusion criteria: Women of age 18-65 years undergoing outpatient hysteroscopy under paracervical block
Exclusion criteria
Exclusion criteria: Women with following conditions: (i)Pregnancy (ii)bradycardia or heart block (iii)known cardiac disease (iv)coagulopathy (v)refusal to consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of dexmedetomidine as an adjuvant in paracervical block on intraprocedural pain assessed by Visual Analog ScaleTimepoint: 15 minutes interval till 2 hours after the procedures | — |
Secondary
| Measure | Time frame |
|---|---|
| Perioperative rescue analgesic requirementTimepoint: From time of insertion of hysteroscope into the uterus ,every 15 minutes until procedure is over and after the procedure for a period of 2 hours;Patient satisfaction measured using Likert ScaleTimepoint: Two hours after the hysteroscopy;Incidence of premature termination and interruption of procedure due to painTimepoint: After the insertion of hysteroscope into the uterus until hysteroscopy is completed;Incidence of nausea, vomiting and giddiness.Timepoint: From the time of giving paracervical block until two hours after the hysteroscopic procedure;Duration of analgesiaTimepoint: From time of completion of paracervical block to request of first rescue analgesic. | — |
Countries
India
Contacts
Public ContactDr Suman Lata
Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry.
Outcome results
None listed